168 related articles for article (PubMed ID: 7603397)
1. Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex.
Hospenthal DR; Byrd JC; Weiss RB
Med Pediatr Oncol; 1995 Aug; 25(2):119-22. PubMed ID: 7603397
[TBL] [Abstract][Full Text] [Related]
2. Successful use of liposome encapsulated amphotericin to treat invasive aspergillosis following failure of conventional amphotericin.
Richards EM; Apperley JF; Marcus RE
Clin Lab Haematol; 1992; 14(2):127-30. PubMed ID: 1633682
[TBL] [Abstract][Full Text] [Related]
3. Case reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy.
Mele L; Pagano L; Equitani F; Leone G
Mycoses; 2001; 44(5):201-3. PubMed ID: 11486459
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
[No Abstract] [Full Text] [Related]
7. Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
Ribner B; Keusch GT; Hanna BA; Perloff M
Chest; 1976 Nov; 70(5):681-3. PubMed ID: 789031
[TBL] [Abstract][Full Text] [Related]
8. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
Ruchlemer R; Yinnon AM; Hershko C
Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
[TBL] [Abstract][Full Text] [Related]
9. Invasive pulmonary aspergillosis complicating pulmonary infarction in a patient with acute myeloblastic leukaemia.
Daly HM; Higgs CM; Scott GL
Clin Lab Haematol; 1984; 6(3):299-303. PubMed ID: 6596155
[No Abstract] [Full Text] [Related]
10. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Manzoor NF; Azim S; Fadoo Z
J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
[TBL] [Abstract][Full Text] [Related]
11. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
12. Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection.
Moreau P; Zahar JR; Milpied N; Baron O; Mahé B; Wu D; Germaud P; Despins P; Delajartre AY; Harousseau JL
Cancer; 1993 Dec; 72(11):3223-6. PubMed ID: 8242545
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
[TBL] [Abstract][Full Text] [Related]
14. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome.
Richard C; Romón I; Baro J; Insunza A; Loyola I; Zurbano F; Tapia M; Iriondo A; Conde E; Zubizarreta A
Bone Marrow Transplant; 1993 Sep; 12(3):237-41. PubMed ID: 8241983
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient.
Cofrancesco E; Boschetti C; Viviani MA; Bargiggia C; Tortorano AM; Cortellaro M; Zanussi C
Haematologica; 1992; 77(3):280-3. PubMed ID: 1427436
[TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients.
Mills W; Chopra R; Linch DC; Goldstone AH
Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068
[TBL] [Abstract][Full Text] [Related]
17. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
18. [A case of pulmonary aspergillosis with the formation of mycetomas in a patient with acute leukemia].
Gurtovenko IIu; Ruzhko VV; Shepetovskaia TI; Iarikova EV
Med Parazitol (Mosk); 1992; (3):59-60. PubMed ID: 1435566
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia.
Mahlknecht U; von Lintig F; Mertelsmann R; Lindemann A; Lübbert M
Leuk Lymphoma; 1997 Sep; 27(1-2):191-4. PubMed ID: 9373212
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.
Van Etten EW; Stearne-Cullen LE; ten Kate M; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2000 Mar; 44(3):540-5. PubMed ID: 10681315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
